OOIR: Observatory of International Research

Papers

(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Facing the unknown suspect: forensic DNA phenotyping and the oscillation between the individual and the collective	23
Rethinking value construction in biomedicine and healthcare	15
Doing the individual and the collective in forensic genetics: governance, race and restitution	11
The coughing body: etiquettes, techniques, sonographies and spaces	10
Life’s continuation: repro-tech, biogenetic affinity, and racial capitalism	9
Core values of genomic citizen science: results from a qualitative interview study	8
Imagining the public: anticipatory discourses in China’s push for precision medicine	7
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	6
‘The good economy’: a conceptual and empirical move for investigating how economies and versions of the good are entangled	6
Powering life through MitoTechnologies: exploring the bio-objectification of mitochondria in reproduction	5
Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca	5
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	5
Psychedelic innovations and the crisis of psychopharmacology	5
The Covid-19 caesura and the post-pandemic future	5
Mutual visibility and interaction: staff reactions to the ‘healing architecture’ of psychiatric inpatient wards in Denmark	5
The emergence of multimorbidity as a matter of concern: a critical review	5
Beyond the making of altruism: branding and identity in egg donation websites in Spain	4
Beyond secrecy and openness: telling a relational story about children’s best interests in donor-conceived families	4
N = many me’s: self-surveillance for Precision Public Health	4
Value-creation in the health data domain: a typology of what health data help us do	4
The datafication of pain: trials and tribulations in measuring phantom limb pain	4
Legitimate suffering: a case of belonging and sickle cell trait in Brazil	4
“Asperger’s syndrome does not exist”: the limits of brain-based identity discourses around Asperger’s syndrome and autism in Italy	3
The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation	3
Acting on uncertainty: real-life mixtures of endocrine disrupting chemicals	3

Device activism and material participation in healthcare: retracing forms of engagement in the #WeAreNotWaiting movement for open-source closed-loop systems in type 1 diabetes self-care	3
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation	3
Fake eggs: from counter-qualification to popular certification in China’s food safety crisis	3
Making valuable health: pharmaceuticals, global capital and alternative political economies	3
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	3
The life and death of confidentiality: a historical analysis of the flows of patient information	3
Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines	3
Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	3
The ongoing work of kinship among donor half-siblings in The Netherlands	3
Concussion killjoys: CTE, violence and the brain’s becoming	3
“It’s harder for the likes of us”: racially minoritised stem cell donation as ethico-racial imperative	3
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property	2
When data drive health: an archaeology of medical records technology	2
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	2
Finding natural variation: assembling underdetermined evidence of gender dysphoria, doing trans therapeutics	2
The politics of Danish IVF: reproducing the nation by making parents through selective reproductive technologies	2
Making it happen: data practices and the power of diplomacy among Danish organ transplant coordinators	2
Making bio-objects mobile: behind the scenes of a translational stem cell banking consortium	2
Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil	2
For a more-than-human public health	2
Openness in donor conception families	2
Sexual health as surplus: the marketization of PrEP in Taiwan	2
Epigenetic citizenship and political claims-making: the ethics of molecularizing structural racism	2
“The elephant in the room”: social responsibility in the production of sociogenomics research	2
The ‘new hysteria’?: wandering wombs, media representations and future imaginaries	2
Keeping race at bay: familial DNA research, the ‘Turkish Community,’ and the pragmatics of multiple collectives in investigative practice	2
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	2
Discipline for pleasure: a new governmentality of HIV prevention	2
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	2
Allostatic load: historical origins, promises and costs of a recent biosocial approach	2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people	2
Post-identifiability in changing sociotechnological genomic data environments	1
How opioids became “safe”: pharmaceutical splitting and the racial politics of opioid safety	1
‘We thank you for your sacrifice’: Clinical vulnerability, shielding and biosociality in the UK’s Covid-19 response	1
Framing regenerative medicine: culturally specific stories of an emerging technoscience	1
Dr. Zahir’s dilemma: money and morals in India’s private medical networks	1
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	1
Analysing bio-art’s epistemic landscape: from metaphoric to post-metaphoric structure	1
Chemical species: the art and politics of living with(out) drugs after addiction	1
Pigs, people and politics: the (re)drawing of Denmark’s biological, politico-geographical, and genomic ‘borders’	1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry	1
The molecularization of race in testosterone research	1
Epidemiologists’ ambivalence towards the epigenetics of social adversity	1
Commentary to: Doing the individual and the collective in forensic genetics: governance, race and restitution	1
Genome editing: From bioethics to biopolitics	1
Organ donation in principle and in practice: tensions and healthcare professionals’ troubled consciences	1
“It gives me time, but does it give me freedom?”: a contextual understanding of anticipatory decision-making in social egg freezing	1
The empire of speculation: medicine, markets, and nation in India’s Pan-African e-Network	1
Race and Biomedicine Beyond the Lab: 21st Century Mobilisations of Genetics—Introduction to the Special Issue	1
Emerging infrastructures: the politics of radium and the validation of radiotherapy in India’s first tertiary cancer hospital	1

Lockdown texts	1
Primate nation: the (after)lives of iconic creatures in American space science	1
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	1
Entrepreneurial treatment activism for undone science: mannitol and Parkinson’s disease	1
Donors we choose: race, nation and the biopolitics of (queer) assisted reproduction in Scandinavia	1
Unstable pharmaceutical values: the grey political economy of drug circulation in Cambodia	1